Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/80787
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChotirmall, Sanjay Hareshen
dc.date.accessioned2017-04-13T06:16:49Zen
dc.date.accessioned2019-12-06T13:58:55Z-
dc.date.available2017-04-13T06:16:49Zen
dc.date.available2019-12-06T13:58:55Z-
dc.date.issued2015en
dc.identifier.citationChotirmall, S. H. (2016). Candida albicans in cystic fibrosis: “Opening statements presented, let the trial begin”. Pediatric Pulmonology, 51(5), 445-446.en
dc.identifier.issn8755-6863en
dc.identifier.urihttps://hdl.handle.net/10356/80787-
dc.description.abstractCystic fibrosis (CF) is a chronic destructive genetic disease resulting from dysfunction of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein that encodes an apically located chloride ion channel on the cellular epithelial surface. Within the lung, this causes mucociliary impairment and consequently an inability to mobilize secretions. The result is mucus trapping, bacterial colonization, recurrent exacerbations, persistent inflammation, structural bronchiectasis and death predominantly attributed to respiratory failure 1,2. Important advances in understanding disease pathogenesis, particularly on a molecular level, coupled with newer therapeutic approaches have increased the life expectancy for patients with CF (PWCF). Such positive change also brings new and previously unrecognized challenges in disease management. One such challenge remains understanding the role of fungal colonization and infection in PWCF.en
dc.format.extent6 p.en
dc.language.isoenen
dc.relation.ispartofseriesPediatric Pulmonologyen
dc.rights© 2015 Wiley Periodicals, Inc. This is the author created version of a work that has been peer reviewed and accepted for publication by Pediatric Pulmonology, Wiley Periodicals, Inc. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1002/ppul.23315].en
dc.subjectCandidaen
dc.subjectCystic Fibrosisen
dc.titleCandida albicans in cystic fibrosis: “Opening statements presented, let the trial begin”en
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.identifier.doi10.1002/ppul.23315en
dc.description.versionAccepted versionen
item.grantfulltextopen-
item.fulltextWith Fulltext-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
Candida albicans in cystic fibrosis- Opening statements presented, let the trial begin.pdf190.21 kBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 50

4
Updated on Jan 13, 2023

Web of ScienceTM
Citations 50

3
Updated on Jan 22, 2023

Page view(s) 50

487
Updated on Jan 29, 2023

Download(s) 50

122
Updated on Jan 29, 2023

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.